Репозиторий Университета

Thromboxane a synthase: A new target for the treatment of cardiovascular diseases

  • Mesitskaya D.
  • Syrkin A.
  • Aksenova M.
  • Zhang Y.
  • Zamyatnin A.
  • Kopylov P.
Дата публикации:01.01.2018
Журнал: Cardiovascular and Hematological Agents in Medicinal Chemistry
БД: Scopus
Ссылка: Scopus
Индекс цитирования: 1


© 2018 Bentham Science Publishers. Atherothrombosis-related diseases are one of the world’s leading causes of mortality, and thus the search for new therapeutic approaches in this area remains a very urgent task. Modern pharmacogenomic technologies make it possible to obtain valuable data on disease pathogenesis and optimal therapeutic approaches. One promising research direction is the study of the thromboxane A2 - thromboxane A synthase - thromboxane A2 receptor axis. This review summarizes the recent evidence and suggests that systematic works in this area are creating new and promising opportunities in the treatment of patients with cardiovascular diseases.

Вернуться назад